Buy or sell Syapse stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Syapse Stock

Syapse enable healthcare providers to deliver the best care to every cancer patient through precision medicine.

About Syapse Stock

Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.

Funding History

January 2011$1.6M
January 2013$3.0M
July 2014$10.0M
January 2016$25.0M
November 2017$30.0M


SVP Product Development

James Lim

Chief Executive Officer

Ken Tarkoff

Founder and President

Jonathan Hirsch

Chief Technology Officer

Tony Loeser

Sr. Product Manager

David Leal

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Syapse or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: